A patch that is provided with a support layer and an adhesive layer, wherein said adhesive layer contains free asenapine, an alkali maleate and a rubber adhesive agent.

An adhesive patch comprising a supporting body layer and an adhesive layer. The adhesive layer contains asenapine and/or a pharmacologically acceptable salt thereof, isopropyl palmitate, and an adhesive base.

A production method for an adhesive patch comprising a supporting body layer and an adhesive layer, said production method including: a mixture preparation step in which asenapine or a pharmacologically acceptable salt thereof and a sodium acetate having a cumulative volume of 50% in the particle size distribution and a particle diameter (D50) of 40-1,000 [mu]m are mixed such that the particle diameter (D50) of the sodium acetate and sodium diacetate generated from the sodium acetate is no more ...

A percutaneous absorption promoter for promoting percutaneous absorption of diclofenac sodium, the promoter containing 1-menthyl glyceryl ether and a petroleum-based resin and/or terpene-based resin

A skin patch provided with a support layer and an adhesive layer, wherein the adhesive layer contains diclofenac sodium, dimethyl sulfoxide, and citric acid

The present invention relates to a medicine adhesive patch and its manufacturing method thereof. The method consisting of manufacturing a support layer and a medicine adhesive patch layer disposed on at least one side of the support layer, and comprising the following steps: (A) obtaining the medicine adhesive patch layer compositions: oxybutynin hydrochloride used as medicine, at least one selected from the group composed of acrylic adhesive based polymer and a rubber polymer used as the adhesi...

The present invention related to a method for producing a patch containing oxybutynin and/or a pharmaceutically acceptable salt as a drug. The invention also related to a patch produced by the method.

The present invention related to a method for producing a patch containing oxybutynin and/or a pharmaceutically acceptable salt as a drug. The invention also related to a patch produced by the method.

An adhesive patch which is provided with a supporting body layer and an adhesive layer. This adhesive patch is characterized in that: the adhesive layer contains diclofenac or a pharmaceutically acceptable salt thereof, glycerol, butylene glycol and polyethylene glycol monooleate

A transdermal absorption preparation containing at least one drug selected from oxybutynin and pharmaceutically acceptable salts thereof, and at least 0.05 mass%, in terms of the total amount of the transdermal absorption preparation, of a sterol selected from cholesterol, cholesterol derivatives, and cholesterol analogs.